enVVeno Medical Statistics
Total Valuation
NVNO has a market cap or net worth of $75.45 million. The enterprise value is $33.82 million.
| Market Cap | 75.45M |
| Enterprise Value | 33.82M |
Important Dates
The next estimated earnings date is Monday, July 29, 2024, after market close.
| Earnings Date | Jul 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NVNO has 13.33 million shares outstanding. The number of shares has increased by 42.97% in one year.
| Shares Outstanding | 13.33M |
| Shares Change (YoY) | +42.97% |
| Shares Change (QoQ) | +30.53% |
| Owned by Insiders (%) | 0.38% |
| Owned by Institutions (%) | 27.71% |
| Float | 13.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.78 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.08, with a Debt / Equity ratio of 0.03.
| Current Ratio | 29.08 |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -62.20% and return on invested capital (ROIC) is -54.81%.
| Return on Equity (ROE) | -62.20% |
| Return on Assets (ROA) | -57.60% |
| Return on Capital (ROIC) | -54.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$713,419 |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.98% in the last 52 weeks. The beta is 1.25, so NVNO's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +21.98% |
| 50-Day Moving Average | 5.10 |
| 200-Day Moving Average | 4.93 |
| Relative Strength Index (RSI) | 56.56 |
| Average Volume (20 Days) | 187,039 |
Short Selling Information
The latest short interest is 959,106, so 7.20% of the outstanding shares have been sold short.
| Short Interest | 959,106 |
| Short Previous Month | 838,507 |
| Short % of Shares Out | 7.20% |
| Short % of Float | 7.22% |
| Short Ratio (days to cover) | 6.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.94M |
| Pretax Income | -22.12M |
| Net Income | -22.12M |
| EBITDA | -21.57M |
| EBIT | -22.12M |
| Earnings Per Share (EPS) | -$1.66 |
Balance Sheet
The company has $42.94 million in cash and $1.32 million in debt, giving a net cash position of $41.63 million or $3.12 per share.
| Cash & Cash Equivalents | 42.94M |
| Total Debt | 1.32M |
| Net Cash | 41.63M |
| Net Cash Per Share | $3.12 |
| Equity (Book Value) | 42.37M |
| Book Value Per Share | 3.18 |
| Working Capital | 41.76M |
Cash Flow
In the last 12 months, operating cash flow was -$17.30 million and capital expenditures -$38,000, giving a free cash flow of -$17.34 million.
| Operating Cash Flow | -17.30M |
| Capital Expenditures | -38,000 |
| Free Cash Flow | -17.34M |
| FCF Per Share | -$1.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NVNO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -42.97% |
| Shareholder Yield | -42.97% |
| Earnings Yield | -29.31% |
| FCF Yield | -22.98% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 30, 2020. It was a reverse split with a ratio of 1:25.
| Last Split Date | Nov 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |